OncoSec Medical Stock Forecast, Price & News

OncoSec Medical (NASDAQ:ONCS) Frequently Asked Questions

Is OncoSec Medical a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OncoSec Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OncoSec Medical stock.
View analyst ratings for OncoSec Medical or view top-rated stocks.

How has OncoSec Medical's stock price been impacted by COVID-19?

OncoSec Medical's stock was trading at $1.37 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ONCS stock has decreased by 12.4% and is now trading at $1.20.
View which stocks have been most impacted by COVID-19.

When is OncoSec Medical's next earnings date?

OncoSec Medical is scheduled to release its next quarterly earnings announcement on Friday, December 10th 2021.
View our earnings forecast for OncoSec Medical.

How were OncoSec Medical's earnings last quarter?

OncoSec Medical Incorporated (NASDAQ:ONCS) posted its quarterly earnings results on Sunday, March, 14th. The biotechnology company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.01.
View OncoSec Medical's earnings history.

When did OncoSec Medical's stock split? How did OncoSec Medical's stock split work?

Shares of OncoSec Medical reverse split on Tuesday, May 21st 2019. The 1-10 reverse split was announced on Monday, May 20th 2019. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 20th 2019. An investor that had 100 shares of OncoSec Medical stock prior to the reverse split would have 10 shares after the split.

What price target have analysts set for ONCS?

3 Wall Street analysts have issued 12 month target prices for OncoSec Medical's shares. Their forecasts range from $10.00 to $12.00. On average, they expect OncoSec Medical's stock price to reach $11.00 in the next twelve months. This suggests a possible upside of 816.7% from the stock's current price.
View analysts' price targets for OncoSec Medical or view top-rated stocks among Wall Street analysts.

Who are OncoSec Medical's key executives?

OncoSec Medical's management team includes the following people:

• Robert J. DelAversano, Vice President-Finance & Controller (LinkedIn Profile)
• Sandra Aung, Chief Clinical Development Officer & Senior VP
• Keir Loiacono, Chief Compliance Officer & Vice President-Legal
• Joe Smith, Vice President-Business Development
• Bridget O'Keeffe, Vice President-Clinical Development

What is Punit Dhillon's approval rating as OncoSec Medical's CEO?

2 employees have rated OncoSec Medical CEO Punit Dhillon on Glassdoor.com. Punit Dhillon has an approval rating of 50% among OncoSec Medical's employees. This puts Punit Dhillon in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of OncoSec Medical's key competitors?

Some companies that are related to OncoSec Medical include Annovis Bio (ANVS), Mustang Bio (MBIO), TFF Pharmaceuticals (TFFP), Frequency Therapeutics (FREQ), Athenex (ATNX), Infinity Pharmaceuticals (INFI), Seelos Therapeutics (SEEL), Inozyme Pharma (INZY), Alzamend Neuro (ALZN), BeyondSpring (BYSI), Larimar Therapeutics (LRMR), Milestone Pharmaceuticals (MIST), NextCure (NXTC), Synlogic (SYBX) and ObsEva (OBSV).
View all of ONCS's competitors.

What other stocks do shareholders of OncoSec Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OncoSec Medical investors own include Cytokinetics (CYTK), Inovio Pharmaceuticals (INO), XOMA (XOMA), Anavex Life Sciences (AVXL), Walt Disney (DIS), Idera Pharmaceuticals (IDRA), Sorrento Therapeutics (SRNE), Amarin (AMRN), Dynavax Technologies (DVAX) and Trevena (TRVN).

What is OncoSec Medical's stock symbol?

OncoSec Medical trades on the NASDAQ under the ticker symbol "ONCS."

Who are OncoSec Medical's major shareholders?

OncoSec Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Two Sigma Advisers LP (0.92%), Geode Capital Management LLC (0.62%), Renaissance Technologies LLC (0.27%), Bank of New York Mellon Corp (0.13%), Tocqueville Asset Management L.P. (0.13%) and Schonfeld Strategic Advisors LLC (0.06%). Company insiders that own OncoSec Medical stock include Alpha Holdings, Inc, Brian A Leuthner, Daniel J O'connor, Grand Pharmaceutical & H China, Robert J Delaversano, Robert J Delaversano, Sara Bonstein and Yuhang Zhao.
View institutional ownership trends for OncoSec Medical.

Which major investors are selling OncoSec Medical stock?

ONCS stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and Schonfeld Strategic Advisors LLC. Company insiders that have sold OncoSec Medical company stock in the last year include Brian A Leuthner, Daniel J O'connor, and Robert J Delaversano.
View insider buying and selling activity for OncoSec Medical or view top insider-selling stocks.

Which major investors are buying OncoSec Medical stock?

ONCS stock was acquired by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Geode Capital Management LLC, Bank of New York Mellon Corp, Goldman Sachs Group Inc., Tocqueville Asset Management L.P., HighTower Advisors LLC, and Citadel Advisors LLC. Company insiders that have bought OncoSec Medical stock in the last two years include Grand Pharmaceutical & H China, and Yuhang Zhao.
View insider buying and selling activity for OncoSec Medical or or view top insider-buying stocks.

How do I buy shares of OncoSec Medical?

Shares of ONCS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OncoSec Medical's stock price today?

One share of ONCS stock can currently be purchased for approximately $1.20.

How much money does OncoSec Medical make?

OncoSec Medical has a market capitalization of $47.04 million. The biotechnology company earns $-45.17 million in net income (profit) each year or ($1.36) on an earnings per share basis.

How many employees does OncoSec Medical have?

OncoSec Medical employs 44 workers across the globe.

What is OncoSec Medical's official website?

The official website for OncoSec Medical is www.oncosec.com.

Where are OncoSec Medical's headquarters?

OncoSec Medical is headquartered at 3565 GENERAL ATOMICS COURT, SAN DIEGO CA, 92121.

How can I contact OncoSec Medical?

OncoSec Medical's mailing address is 3565 GENERAL ATOMICS COURT, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at (858) 662-6732, via email at [email protected], or via fax at 858-430-3832.